1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Digital Therapeutics Market
2.2. Global Digital Therapeutics Market, By Product, 2023 (US$ Million)
2.3. Global Digital Therapeutics Market, By Application, 2023 (US$ Million)
2.4. Global Digital Therapeutics Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023
3. Digital Therapeutics Market: Competitive Analysis
3.1. Market Positioning of Key Digital Therapeutics Market Vendors
3.2. Strategies Adopted by Digital Therapeutics Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2023 Versus 2032
4. Digital Therapeutics Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Digital Therapeutics Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape
7. North America Digital Therapeutics Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Digital Therapeutics Market: By Product, 2022-2032, USD (Million)
7.3. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
7.4.Digital Therapeutics Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Digital Therapeutics Market: By Product, 2022-2032, USD (Million)
7.4.1.1.2. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Digital Therapeutics Market: By Product, 2022-2032, USD (Million)
7.4.1.2.2. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Digital Therapeutics Market: By Product, 2022-2032, USD (Million)
7.4.1.3.2. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
8. UK and European Union Digital Therapeutics Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Digital Therapeutics Market: By Product, 2022-2032, USD (Million)
8.3. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
8.4.Digital Therapeutics Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Digital Therapeutics Market: By Product, 2022-2032, USD (Million)
8.4.1.1.2. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Digital Therapeutics Market: By Product, 2022-2032, USD (Million)
8.4.1.2.2. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Digital Therapeutics Market: By Product, 2022-2032, USD (Million)
8.4.1.3.2. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Digital Therapeutics Market: By Product, 2022-2032, USD (Million)
8.4.1.4.2. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Digital Therapeutics Market: By Product, 2022-2032, USD (Million)
8.4.1.5.2. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Digital Therapeutics Market: By Product, 2022-2032, USD (Million)
8.4.1.6.2. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
9. Asia Pacific Digital Therapeutics Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Digital Therapeutics Market: By Product, 2022-2032, USD (Million)
9.3. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
9.4.Digital Therapeutics Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Digital Therapeutics Market: By Product, 2022-2032, USD (Million)
9.4.1.1.2. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Digital Therapeutics Market: By Product, 2022-2032, USD (Million)
9.4.1.2.2. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Digital Therapeutics Market: By Product, 2022-2032, USD (Million)
9.4.1.3.2. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Digital Therapeutics Market: By Product, 2022-2032, USD (Million)
9.4.1.4.2. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Digital Therapeutics Market: By Product, 2022-2032, USD (Million)
9.4.1.5.2. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Digital Therapeutics Market: By Product, 2022-2032, USD (Million)
9.4.1.6.2. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
10. Latin America Digital Therapeutics Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Digital Therapeutics Market: By Product, 2022-2032, USD (Million)
10.3. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
10.4.Digital Therapeutics Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Digital Therapeutics Market: By Product, 2022-2032, USD (Million)
10.4.1.1.2. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Digital Therapeutics Market: By Product, 2022-2032, USD (Million)
10.4.1.2.2. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Digital Therapeutics Market: By Product, 2022-2032, USD (Million)
10.4.1.3.2. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
11. Middle East and Africa Digital Therapeutics Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Digital Therapeutics Market: By Product, 2022-2032, USD (Million)
11.3. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
11.4.Digital Therapeutics Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Digital Therapeutics Market: By Product, 2022-2032, USD (Million)
11.4.1.1.2. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Digital Therapeutics Market: By Product, 2022-2032, USD (Million)
11.4.1.2.2. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Digital Therapeutics Market: By Product, 2022-2032, USD (Million)
11.4.1.3.2. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
12. Company Profile
12.1. 2Morrow, Inc.
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Canary Health, Inc.
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Doximity, Inc.
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Evolent Health, Inc.
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Livongo Health
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Mango Health, Inc.
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Nanobiosym, Inc.
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Noom Health, Inc.
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Omada Health, Inc.
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Pear Therapeutics, Inc.
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives
12.11. Perfint Healthcare Pvt. Ltd.
12.11.1. Company Overview
12.11.2. Financial Performance
12.11.3. Product Portfolio
12.11.4. Strategic Initiatives
12.12. Propeller Health
12.12.1. Company Overview
12.12.2. Financial Performance
12.12.3. Product Portfolio
12.12.4. Strategic Initiatives
12.13. Proteus Digital Health
12.13.1. Company Overview
12.13.2. Financial Performance
12.13.3. Product Portfolio
12.13.4. Strategic Initiatives
12.14. Twinehealth, Inc.
12.14.1. Company Overview
12.14.2. Financial Performance
12.14.3. Product Portfolio
12.14.4. Strategic Initiatives
12.15. WellDoc Inc.
12.15.1. Company Overview
12.15.2. Financial Performance
12.15.3. Product Portfolio
12.15.4. Strategic Initiatives
12.16. Zest Health
12.16.1. Company Overview
12.16.2. Financial Performance
12.16.3. Product Portfolio
12.16.4. Strategic Initiatives